Top Markets
#1 0G 0G +11.60%
#2 Siacoin Siacoin +9.25%
#3 Cash Cat Cash Cat +8.48%
#4 Arbitrum Arbitrum +7.02%
#5 MarsCoin MarsCoin +6.90%
#6 Asteroid Shiba Asteroid Shiba +6.90%
#7 Seeker Seeker +6.12%
#8 Metis Metis +6.04%
#9 Useless Coin Useless Coin +5.01%
#10 Optimism Optimism +4.77%
Coin of the day
0G 0G
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Carlsmed, Inc. Carlsmed, Inc.

Carlsmed, Inc.

CARL
Pozycja w akcjach #14037
Carlsmed, Inc., a commercial-stage medical technology company, designs,... Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
Cena akcji
$16.23
Ostatnia synchronizacja: 2026-08-31
Kapitalizacja rynkowa
$441.21M
Zmiana (1 dzień)
-3.85%
Zmiana (1 rok)
22.03%
Kraj
US
Handel Carlsmed, Inc. (CARL)

Kategoria

Healthcare
Historia stopy dywidendy dla Carlsmed, Inc. (CARL)
Stopa dywidendy (TTM) dla Carlsmed, Inc. (symbol akcji: CARL) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Carlsmed, Inc. (CARL) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
Firma Stopa dywidendy Kraj
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
2.23%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
1.03%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
3.69%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
0.00%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
0.00%
US